CreditRiskMonitor is a financial risk analysis and news service for credit, supply chain and financial professionals.  Our strength in coverage spans 58,000 global public companies, totaling about $70 trillion in corporate revenue.  We also offer solutions that can help ease private company financial risk assessment.  Leading corporations around the world – including more than 35% of the Fortune 1000, plus thousands more worldwide – rely on us to help them stay ahead of financial risk quickly, accurately and cost-effectively. 

A partial report preview for TransGenic Group Inc is shown below.  Where indicated by "Yes," CreditRiskMonitor contains this information in its extensive database.  To get access to the full report and learn more about CreditRiskMonitor's robust financial risk analysis and timely news service, request a personalized demo and free trial today.

If you are already a subscriber and want to access the full report, click here.

TransGenic Group Inc
ibbFUKUOKA Bldg.
2-3-36, Tenjin, Chuo-ku
Phone: +81 922888470p:+81 922888470 FUKUOKA-SHI, FKK  810-0001  Japan Ticker: 23422342

Business Summary
TransGenic Group Inc, formerly Trans Genic Inc is a Japan-based company mainly engaged in the drug discovery support business and the investment and consulting business. The Company operates through two business segments. The Drug Discovery Support Business segment provides seamless services that can handle all stages of drug discovery, from the initial stages of drug discovery, such as basic research and drug discovery research, to non-clinical and clinical trials. Its main services include contract production of genetically modified mice, contract production of antibodies and glycosylation analysis and synthesis. The Investment and Consulting Business segment promotes new businesses through mergers and acquisitions (M&A) and provides advice and support services related to business succession and business revitalization in a wide range of fields.

Scores and Ratings
FRISK®
Score
Z''
Score
PAYCE®
Score
DBT
Index
Moody's
Rating
Fitch
Rating
DBRS
Rating
YesYes-----

Financials, News and Filings
Latest
Statement
Last
Audit

News
SEC
Filings
Bankruptcy
Filings
Suit &
Judgment
Filings
Tax
Lien
Filings
9/30/20243/31/2024Yes----

Officers and Directors

Title

Name

Age
Title
Date
Start
Date
President, Chief Executive Officer, President of Subsidiaries, Representative Director KenjiFukunaga 53 3/1/2018 6/23/2009
Director of Accounting and Finance, Director KazuoWatanabe 55 6/1/2018 7/1/2017
Manager of IR & Corporate Management, Manager of Information Management, Director YutakaFunabashi 49 6/1/2011 6/1/2011
6 additional Officers and Directors records available in full report.

Business Names
Business Name
2342
GeneticLab Co., Ltd
INCOM Co.,LTD
Outlet Plaza
Primmune Inc.

General Information
Number of Employees: 236 (As of 3/31/2024)
Outstanding Shares: 16,653,219 (As of 9/30/2024)
Shareholders: 12,256
Stock Exchange: TYO
Fax Number: +81 922888473


Copyright © 2024 CreditRiskMonitor.com (Ticker: CRMZ). All rights reserved.     
By using this website, you accept the Terms of Use Agreement.
Monday, December 2, 2024